|
Market Closed -
Other stock markets
|
Pre-market 12:21:52 pm | |||
| 19.00 EUR | -7.99% |
|
19.22 | +1.16% |
| 08/12 | STABILUS : Warburg Research reiterates its Buy rating | ZD |
| 08/12 | Stabilus SE Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2025 | CI |
| Fiscal Period: September | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.49 | 6.76 | 7.29 | 6.98 | 4.87 | |||||
Return on Total Capital | 5.96 | 8.9 | 9.66 | 9.25 | 6.32 | |||||
Return On Equity % | 6.19 | 14.55 | 17.19 | 14.95 | 10.37 | |||||
Return on Common Equity | 6.6 | 14.67 | 17.09 | 15.09 | 10.52 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 28.32 | 29.89 | 27.88 | 26.53 | 26.35 | |||||
SG&A Margin | 14.25 | 12.8 | 11.34 | 12.24 | 14.52 | |||||
EBITDA Margin % | 15.05 | 17.45 | 16.69 | 15.7 | 14.98 | |||||
EBITA Margin % | 11.68 | 14.46 | 13.98 | 13.14 | 12.07 | |||||
EBIT Margin % | 9.53 | 12.97 | 12.71 | 11.96 | 9.69 | |||||
Income From Continuing Operations Margin % | 3.65 | 7.87 | 9.35 | 8.5 | 5.52 | |||||
Net Income Margin % | 3.82 | 7.83 | 9.22 | 8.38 | 5.37 | |||||
Net Avail. For Common Margin % | 3.82 | 7.83 | 9.22 | 8.38 | 5.37 | |||||
Normalized Net Income Margin | 5.69 | 7.09 | 7.9 | 6.27 | 5.11 | |||||
Levered Free Cash Flow Margin | 6.47 | 7.29 | 3.46 | 5.74 | 5.2 | |||||
Unlevered Free Cash Flow Margin | 7.3 | 8.17 | 4.26 | 6.4 | 6.76 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.75 | 0.83 | 0.92 | 0.93 | 0.8 | |||||
Fixed Assets Turnover | 3.83 | 4.14 | 4.94 | 5.11 | 4.77 | |||||
Receivables Turnover (Average Receivables) | 6.65 | 7.64 | 6.91 | 6.32 | 6.6 | |||||
Inventory Turnover (Average Inventory) | 5.97 | 5.62 | 5.29 | 5.18 | 4.8 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.15 | 2.57 | 2.55 | 2.64 | 1.97 | |||||
Quick Ratio | 1.55 | 1.75 | 1.69 | 1.76 | 1.1 | |||||
Operating Cash Flow to Current Liabilities | 0.58 | 0.67 | 0.57 | 0.78 | 0.68 | |||||
Days Sales Outstanding (Average Receivables) | 55.07 | 47.76 | 52.85 | 57.74 | 55.48 | |||||
Days Outstanding Inventory (Average Inventory) | 61.35 | 64.99 | 68.99 | 70.46 | 76.26 | |||||
Average Days Payable Outstanding | 50.59 | 42.27 | 44.65 | 49.44 | 51.54 | |||||
Cash Conversion Cycle (Average Days) | 65.83 | 70.48 | 77.19 | 78.76 | 80.21 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 77.16 | 60.96 | 43.36 | 40.92 | 121.14 | |||||
Total Debt / Total Capital | 43.55 | 37.87 | 30.25 | 29.04 | 54.78 | |||||
LT Debt/Equity | 68.39 | 59.37 | 41.93 | 38.83 | 116.68 | |||||
Long-Term Debt / Total Capital | 38.6 | 36.89 | 29.25 | 27.55 | 52.77 | |||||
Total Liabilities / Total Assets | 56.66 | 53.34 | 47.13 | 46.64 | 64.53 | |||||
EBIT / Interest Expense | 7.11 | 9.26 | 10.01 | 11.28 | 3.87 | |||||
EBITDA / Interest Expense | 11.98 | 13.08 | 13.73 | 15.42 | 6.28 | |||||
(EBITDA - Capex) / Interest Expense | 9.27 | 11.53 | 11.87 | 11.73 | 4.64 | |||||
Total Debt / EBITDA | 2.75 | 1.93 | 1.49 | 1.47 | 4.01 | |||||
Net Debt / EBITDA | 1.52 | 0.81 | 0.63 | 0.49 | 3.47 | |||||
Total Debt / (EBITDA - Capex) | 3.55 | 2.19 | 1.73 | 1.93 | 5.42 | |||||
Net Debt / (EBITDA - Capex) | 1.96 | 0.92 | 0.73 | 0.65 | 4.7 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -13.58 | 14.05 | 19.06 | 8.86 | 7.46 | |||||
Gross Profit, 1 Yr. Growth % | -15.77 | 20.39 | 11.05 | 8.45 | 6.72 | |||||
EBITDA, 1 Yr. Growth % | -25.45 | 32.23 | 12.78 | 0.55 | -7.85 | |||||
EBITA, 1 Yr. Growth % | -30.99 | 41.19 | 13.76 | 0.1 | -9.04 | |||||
EBIT, 1 Yr. Growth % | -34.72 | 55.22 | 15.11 | 2.44 | -10.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -62.93 | 145.95 | 41.47 | -0.99 | -30.28 | |||||
Net Income, 1 Yr. Growth % | -61.01 | 133.49 | 40.29 | -1.14 | -31.05 | |||||
Normalized Net Income, 1 Yr. Growth % | -33.27 | 42.21 | 30.79 | -13.64 | -9.39 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -61.04 | 133.86 | 40.35 | -1.16 | -31.07 | |||||
Accounts Receivable, 1 Yr. Growth % | -10.17 | 15.96 | 45.36 | 0.7 | 5.23 | |||||
Inventory, 1 Yr. Growth % | -3.09 | 40.78 | 22.33 | 5.85 | 26.14 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 14.94 | -2.9 | 2.57 | 7.98 | 21.51 | |||||
Total Assets, 1 Yr. Growth % | -1.43 | 7.67 | 8.57 | 5.35 | 43.21 | |||||
Tangible Book Value, 1 Yr. Growth % | 49.24 | 107.61 | 73.93 | -5.63 | -225.54 | |||||
Common Equity, 1 Yr. Growth % | -5.83 | 16.8 | 23.42 | 2.74 | -4.95 | |||||
Cash From Operations, 1 Yr. Growth % | -25.12 | 18.46 | -2.52 | 41.65 | 10.6 | |||||
Capital Expenditures, 1 Yr. Growth % | -27.76 | -32.29 | 30.17 | 80.6 | 12.46 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.36 | 28.6 | -44.27 | 75.15 | 1.02 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.85 | 27.52 | -38.75 | 59.83 | 17.33 | |||||
Dividend Per Share, 1 Yr. Growth % | -54.55 | 150 | 40 | 0 | -34.29 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -7.58 | -0.72 | 16.53 | 13.84 | 8.16 | |||||
Gross Profit, 2 Yr. CAGR % | -10.58 | 0.7 | 15.62 | 7.25 | 7.58 | |||||
EBITDA, 2 Yr. CAGR % | -16.33 | -0.71 | 22.71 | 7.48 | 1.51 | |||||
EBITA, 2 Yr. CAGR % | -20.31 | -1.29 | 27.48 | 7.9 | -0.61 | |||||
EBIT, 2 Yr. CAGR % | -23.37 | 0.66 | 34.55 | 8.59 | -5.56 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -46.65 | -4.52 | 86.53 | 18.35 | -16.91 | |||||
Net Income, 2 Yr. CAGR % | -45.39 | -4.59 | 80.99 | 17.76 | -17.44 | |||||
Normalized Net Income, 2 Yr. CAGR % | -23.61 | -2.59 | 37.4 | 6.27 | -13.04 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -45.45 | -4.55 | 81.17 | 17.78 | -17.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.57 | 0.54 | 29.83 | 21.01 | 2.94 | |||||
Inventory, 2 Yr. CAGR % | 3.5 | 16.8 | 31.23 | 13.79 | 15.55 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.24 | 5.64 | -0.2 | 5.24 | 14.55 | |||||
Total Assets, 2 Yr. CAGR % | 3.56 | 3.02 | 8.12 | 6.95 | 22.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | 49.8 | 76.02 | 90.02 | 23.07 | 8.85 | |||||
Common Equity, 2 Yr. CAGR % | 4.03 | 4.88 | 20.06 | 12.6 | -1.18 | |||||
Cash From Operations, 2 Yr. CAGR % | -13.48 | -5.82 | 7.46 | 17.51 | 25.16 | |||||
Capital Expenditures, 2 Yr. CAGR % | -9.63 | -30.07 | -6.12 | 53.33 | 42.51 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -18.92 | 14.17 | -14.73 | 0.28 | 30.55 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -16.82 | 13.96 | -11.05 | 0.15 | 34.67 | |||||
Dividend Per Share, 2 Yr. CAGR % | -29.29 | 6.6 | 87.08 | 18.32 | -18.94 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -3.33 | -0.87 | 5.48 | 13.91 | 11.68 | |||||
Gross Profit, 3 Yr. CAGR % | -5.15 | -1.26 | 4.04 | 11.46 | 7.08 | |||||
EBITDA, 3 Yr. CAGR % | -9.71 | -2.54 | 3.93 | 15.54 | 5.79 | |||||
EBITA, 3 Yr. CAGR % | -12.24 | -3.57 | 3.89 | 18.48 | 4.74 | |||||
EBIT, 3 Yr. CAGR % | -14.21 | -3.04 | 5.72 | 22.86 | 0.88 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -27.67 | -11.21 | 8.85 | 51.03 | -0.79 | |||||
Net Income, 3 Yr. CAGR % | -26.53 | -11.37 | 8.49 | 47.94 | -1.48 | |||||
Normalized Net Income, 3 Yr. CAGR % | -12.92 | -6.03 | 8 | 17.69 | -0.37 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -26.58 | -11.38 | 8.54 | 48.04 | -1.48 | |||||
Accounts Receivable, 3 Yr. CAGR % | 3.65 | 5.79 | 13.69 | 19.3 | 15.5 | |||||
Inventory, 3 Yr. CAGR % | 4.48 | 14.68 | 18.61 | 22.16 | 17.77 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.64 | 7.58 | 4.61 | 2.45 | 10.41 | |||||
Total Assets, 3 Yr. CAGR % | 5.23 | 4.91 | 4.84 | 7.18 | 17.88 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.47 | 67.01 | 75.32 | 46.5 | 23.89 | |||||
Common Equity, 3 Yr. CAGR % | 11.14 | 8.13 | 10.73 | 13.99 | 6.42 | |||||
Cash From Operations, 3 Yr. CAGR % | -3.7 | -3.93 | -4.73 | 17.83 | 15.16 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.7 | -17.92 | -13.97 | 16.76 | 38.28 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -6.6 | -5.44 | -9.67 | 9.48 | -0.72 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -6.55 | -4.09 | -6.94 | 9.02 | 4.41 | |||||
Dividend Per Share, 3 Yr. CAGR % | -14.5 | 7.72 | 16.74 | 51.83 | -2.74 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.11 | 4.92 | 4.17 | 4.77 | 6.54 | |||||
Gross Profit, 5 Yr. CAGR % | 9.53 | 8.11 | 2.67 | 2.06 | 4.48 | |||||
EBITDA, 5 Yr. CAGR % | 7.43 | 6.65 | 2.08 | 1.55 | 3.34 | |||||
EBITA, 5 Yr. CAGR % | 8.51 | 7.91 | 1.9 | 1.1 | 2.52 | |||||
EBIT, 5 Yr. CAGR % | 7.71 | 8.72 | 2.71 | 1.72 | 1.06 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.02 | 8.98 | 5.66 | -0.39 | -2.3 | |||||
Net Income, 5 Yr. CAGR % | 13.15 | 8.88 | 5.37 | -0.7 | -2.74 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.52 | 8.5 | 4.5 | -1 | -0.97 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.2 | 6.09 | 5.37 | -0.7 | -2.72 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.25 | 6.18 | 12.74 | 11.63 | 9.27 | |||||
Inventory, 5 Yr. CAGR % | 10.22 | 12.88 | 14.45 | 14.32 | 17.38 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.4 | 5.9 | 6.17 | 6.64 | 8.48 | |||||
Total Assets, 5 Yr. CAGR % | 14.85 | 4.47 | 6.37 | 5.72 | 11.69 | |||||
Tangible Book Value, 5 Yr. CAGR % | 0.58 | 0.39 | 33.48 | 47.81 | 42.58 | |||||
Common Equity, 5 Yr. CAGR % | 43.19 | 15.46 | 14.62 | 9.9 | 5.8 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.83 | 3.15 | 0.62 | 4.13 | 6.26 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.67 | -12.68 | -4.68 | 5.39 | 5.27 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 14.08 | 21.71 | -9.94 | -2.91 | 5.29 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 6.23 | 17.71 | -8.38 | -2.16 | 8.41 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 20.11 | 16.95 | 11.84 | 0.89 |
- Stock Market
- Equities
- STM Stock
- Financials Stabilus SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















